AIS Healthcare

AIS Healthcare provides nationwide commercial pharmacy, compounding, and infusion care services for chronic pain, immunological, and rare disease indications. Their TDD and AIC divisions deliver both individualized compounding for intrathecal pump therapy and a broad portfolio of infusion options, including immunoglobulins, all supported by a large national nursing team. No drug pipeline or proprietary clinical trials are reported. AIS Healthcare is a leading, privately held US healthcare company specializing in specialty pharmacy, compounding, and home infusion medication compounding, with an industry-leading focus on chronic pain (targeted drug delivery via intrathecal pump) and select rare immunological indications. Not a biotech or pharma R&D company; does not run clinical trials or own a R&D pipeline – instead, it distributes, dispenses, compounds, and coordinates delivery of FDA-approved medications. Therapeutic modalities include small molecules and biologics (immunoglobulins, Alpha-1 protein).